123 related articles for article (PubMed ID: 2509867)
1. Tissue doses from radiotherapy of cancer of the uterine cervix.
Stovall M; Smith SA; Rosenstein M
Med Phys; 1989; 16(5):726-33. PubMed ID: 2509867
[TBL] [Abstract][Full Text] [Related]
2. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
3. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
4. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source.
Suleiman SA; Qi Y; Chen Z; Xu XG
Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393
[TBL] [Abstract][Full Text] [Related]
5. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
6. The results of treatment of carcinoma of the uterine cervix using a linear vaginal source and 4 MV X rays.
Brand MA; Kerr GR
Br J Radiol; 1982 May; 55(653):352-5. PubMed ID: 6805545
[TBL] [Abstract][Full Text] [Related]
7. Build-up and surface dose measurements on phantoms using micro-MOSFET in 6 and 10 MV x-ray beams and comparisons with Monte Carlo calculations.
Xiang HF; Song JS; Chin DW; Cormack RA; Tishler RB; Makrigiorgos GM; Court LE; Chin LM
Med Phys; 2007 Apr; 34(4):1266-73. PubMed ID: 17500458
[TBL] [Abstract][Full Text] [Related]
8. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
Mille MM; Xu XG; Rivard MJ
Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
[TBL] [Abstract][Full Text] [Related]
9. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
Chibani O; C-M Ma C
Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
[TBL] [Abstract][Full Text] [Related]
10. Radical radiotherapy for carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique: the Clatterbridge technique.
Tan LT; Jones B; Shaw JE
Br J Radiol; 1997 Dec; 70(840):1252-8. PubMed ID: 9505844
[TBL] [Abstract][Full Text] [Related]
11. [Combined treatment of carcinoma of the cervix by radium and x-rays extended field of the betatron 42 MeV with field protraction].
Tacev T; Krystof V; Spurný V; Caha A; Ott O; Kucera F; Ptácková B; Kabela M
Cesk Radiol; 1980 May; 34(3):174-81. PubMed ID: 6772316
[No Abstract] [Full Text] [Related]
12. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
[TBL] [Abstract][Full Text] [Related]
13. Doses on the central axes of narrow 6-MV x-ray beams.
Bjärngard BE; Tsai JS; Rice RK
Med Phys; 1990; 17(5):794-9. PubMed ID: 2122197
[TBL] [Abstract][Full Text] [Related]
14. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
Sharma R; Jursinic PA
Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
[TBL] [Abstract][Full Text] [Related]
15. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoma of the uterine cervix stage III and IV--treatment, results and complications (author's transl)].
Kucera H; Gerstner G; Weghaupt K
Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):457-61. PubMed ID: 6809523
[No Abstract] [Full Text] [Related]
17. [Variability of dose distribution in intracavity irradiation of cancer of the cervix uteri using radium].
Tacev T; Krystof V
Cesk Radiol; 1984 May; 38(3):216-21. PubMed ID: 6744460
[No Abstract] [Full Text] [Related]
18. [Factors influencing the absorbed dose at points A and B during intracavitary radiotherapy of cancer of the cervix].
Minchenkova EA; Kallinger W; Skoropad IuD
Vopr Onkol; 1991; 37(7-8):812-7. PubMed ID: 1842634
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate afterloading brachytherapy in carcinoma of the uterine cervix.
Chiou JF; Liu MT; Lai YL; Chang KH
J Formos Med Assoc; 1993 Feb; 92(2):165-73. PubMed ID: 8101746
[TBL] [Abstract][Full Text] [Related]
20. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
Selvam TP; Sahoo S; Vishwakarma RS
Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
